Business Description
Lantern Pharma Inc
NAICS : 325412
SIC : 2834
ISIN : US51654W1018
Share Class Description:
LTRN: Ordinary SharesDescription
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 176.51 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -6.3 | |||||
| 3-Year EPS without NRI Growth Rate | -2.4 | |||||
| 3-Year FCF Growth Rate | -0.2 | |||||
| 3-Year Book Growth Rate | 6.4 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.81 | |||||
| 9-Day RSI | 35.31 | |||||
| 14-Day RSI | 40.89 | |||||
| 6-1 Month Momentum % | 292.27 | |||||
| 12-1 Month Momentum % | 118.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.18 | |||||
| Quick Ratio | 16.18 | |||||
| Cash Ratio | 15.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.9 | |||||
| Shareholder Yield % | -0.26 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -32.82 | |||||
| ROA % | -31.03 | |||||
| ROIC % | -2204.32 | |||||
| ROC (Joel Greenblatt) % | -2380.43 | |||||
| ROCE % | -36.69 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.51 | |||||
| Price-to-Tangible-Book | 1.52 | |||||
| EV-to-EBIT | -1.13 | |||||
| EV-to-Forward-EBIT | -0.81 | |||||
| EV-to-EBITDA | -1.13 | |||||
| EV-to-Forward-EBITDA | -0.06 | |||||
| EV-to-FCF | -1.4 | |||||
| Price-to-Net-Current-Asset-Value | 1.53 | |||||
| Price-to-Net-Cash | 1.61 | |||||
| Earnings Yield (Greenblatt) % | -88.5 | |||||
| FCF Yield % | -23.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LTRN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lantern Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.48 | ||
| Beta | 1.3 | ||
| Volatility % | 111.96 | ||
| 14-Day RSI | 40.89 | ||
| 14-Day ATR ($) | 0.894891 | ||
| 20-Day SMA ($) | 7.39 | ||
| 12-1 Month Momentum % | 118.24 | ||
| 52-Week Range ($) | 2.38 - 11.99 | ||
| Shares Outstanding (Mil) | 10.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lantern Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lantern Pharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lantern Pharma Inc Frequently Asked Questions
What is Lantern Pharma Inc(LTRN)'s stock price today?
The current price of LTRN is $5.80. The 52 week high of LTRN is $11.99 and 52 week low is $2.38.
When is next earnings date of Lantern Pharma Inc(LTRN)?
The next earnings date of Lantern Pharma Inc(LTRN) is 2024-05-09 Est..
Does Lantern Pharma Inc(LTRN) pay dividends? If so, how much?
Lantern Pharma Inc(LTRN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers